Clinical trial

ARBITER-II: Aorfix™ Bifurcated Safety and Performance Trial: Phase II, Angulated…

NCT00442065 · Lombard Medical, Industry · Completed

Key facts

NCT number NCT00442065
Title ARBITER-II: Aorfix™ Bifurcated Safety and Performance Trial: Phase II, Angulated Vessels
Official title A Study to Assess the Acute Technical Success of Aorfix™ Stent Grafts in the Treatment of Abdominal Aortic and Aorto-Iliac Aneurysm Where a Significant Degree of Vessel Angulation Exists at the Neck of the Aneurysm
Acronym ARBITER-II
Lead sponsor Lombard Medical, Industry
Status Completed
Phase Phase 2/Phase 3
Study type Interventional
Conditions Abdominal Aortic Aneurysm
Intervention type Device
Interventions Aorfix™ Stent Grafts (AAA endovascular procedure)
Enrollment 30
Start date Oct 1, 2006
Primary completion Apr 1, 2009
Completion Apr 1, 2009
First posted Mar 1, 2007
Last update posted Oct 17, 2012
Countries Czechia, Germany, Poland, Spain, United Kingdom

At a glance

  • 1–9 Study sites
  • No Results posted
  • 1–9 Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies